Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists
PHILADELPHIA, June 17, 2026 (GLOBE NEWSWIRE) — Proscia® at this time launched the Fifth Technology of its Concentriq®1 platform, serving to pathologists deal with high-judgment choices and enabling scientists to rapidly transfer from early alerts to evidence-based program choices. Proscia is trusted by diagnostic laboratories that handle 12 million affected person instances yearly and 16 of the highest 20 pharmaceutical firms.
Pathology sits on the heart of how illness is known and handled. But greater than half of pathologists report not having sufficient time to get by means of their workload,2 whereas scientists face mounting stress to carry focused therapies to sufferers, whilst most investigational medicines by no means attain the market. Fifth Technology introduces intelligence that pulls on scientific and scientific context to assist consultants all through drug discovery, improvement, and case assessment.
Making this intelligence native to Concentriq required a brand new structure. Designed alongside pathologists and scientists, Fifth Technology is probably the most vital development to Concentriq in 5 years. It brings domain-specific frontier imaginative and prescient, language, and multimodal fashions to the core of a know-how stack constructed for enterprise-scale safety, governance, and reliability.
This structure permits the platform to unify pictures, metadata, and the context surrounding a case or examine — from slide-level morphology and affected person historical past to laboratory-specific protocols and translational information — giving consultants and fashions the identical full image. Intelligence attracts on this image to orchestrate the burdensome work surrounding case assessment and speed up the invention and improvement of superior biomarkers. Outputs are clear, reproducible, and interpretable for skilled verification.
“AI is advancing quickly,” stated Coleman Stavish, CTO of Proscia. “We took a first-principles strategy, working backwards from how pathologists and scientists function. Years of studying from our prospects have helped us perceive the place complexity slows them down and the place judgment will get crowded out by course of. Fifth Technology is designed to cut back that burden so consultants can deal with the choices that matter most.”
How Does Concentriq Assist Pathologists and Diagnostic Laboratories?
Named 2026 Best in KLAS for Digital Pathology, Concentriq permits pathologists and laboratories to make a higher affect.
Speed up case assessment
Concentriq brings the move state of the microscope to an enterprise-scale digital platform, combining the microscope’s tactile nature with an understanding of the case and context. Clever navigation helps pathologists transfer rapidly by means of tissue whereas pores and skin slides orient mechanically to protect the psychological mannequin wanted to evaluate findings resembling depth of invasion. Context stays related to the case in order that pathologists can transfer effectively by means of duties like lymph node counts. Picture evaluation is constructed instantly into the viewer, permitting areas of curiosity to be refined and outcomes to replace in actual time with supporting proof out there for skilled verification. Reportable findings are assembled in the identical go for pathologist affirmation. The result’s higher focus and velocity with much less guide effort.
Automate laboratory operations
Operations groups preserve tempo with rising case volumes whereas sustaining turnaround occasions. AI helps stability workloads, suggest stain panels and ancillary research, and floor operational bottlenecks earlier than they affect efficiency. Function-built worklists and dashboards present visibility throughout websites and scanners, serving to groups preserve instances transferring with out switching instruments or chasing down updates. Automated storage tiering matches placement to how every web site makes use of its information, decreasing long-term storage prices by greater than half3 whereas preserving safe, ruled entry to the instances that energy re-review, future AI validation, and biopharmaceutical collaborations.
Drive enterprise progress
Laboratories can broaden into high-margin specialty testing and develop their position in precision medication. Molecular workflows inside Concentriq scale back guide handoffs and optimize tissue at each step with digital macrodissection and native AI tumor detection, making superior molecular testing simpler to scale with high-quality information. By means of the community Concentriq permits, laboratories can collaborate with biopharmaceutical firms on real-world information packages, scientific trials, and companion diagnostic improvement, amongst different initiatives.
“As one of many first laboratories to go digital, we’ve seen firsthand how know-how reshapes pathology, and Concentriq has enabled that journey,” stated Dr. Derek Welch, President and Chief Medical Officer of PathGroup. “Fifth Technology applies AI in a completely new manner, eradicating the invisible labor that surrounds case assessment so pathologists can spend extra time on the choices that solely they’ll make.”
How Does Concentriq Assist Scientists and Biopharmaceutical Firms?
Concentriq helps the precision medication lifecycle by serving to biopharmaceutical firms uncover biomarkers and develop therapies whereas making a community for matching sufferers to the suitable therapies.
Speed up biomarker discovery
Scientists can transfer from inquiries to solutions sooner. A scientist begins with a query in plain language and may search throughout tissue, scientific and translational information, and Proscia’s multimodal information basis. Brokers floor related proof, suggest evaluation pipelines that scientists can edit, model, and run, and assist establish promising biomarker candidates and assess their efficiency. As new findings move again into discovery, scientists can construct on prior work relatively than begin from scratch.
Improve scientific trial success
Medical improvement groups carry diagnostic precision to the choices that outline a trial. Algorithms predict biomarker expression throughout pre-screening in order that sponsors can establish eligible sufferers and attain enrollment objectives sooner. Concentriq helps biomarker-driven research on the scale of worldwide multi-site trials, serving to guarantee sufferers are evaluated towards constant standards and producing reproducible, dependable outcomes.
Broaden affected person entry
Precision medication groups can carry biomarkers and companion diagnostics into routine scientific use. Concentriq helps groups constructing and validating assays with entry to multimodal real-world information that allows biomarker validation and the manufacturing of proof required for regulatory approval. With tens of millions of affected person instances recognized yearly throughout tutorial, reference, and well being system laboratories, Concentriq additionally helps carry validated diagnostics from approval to broad scientific adoption at scale.
“We use Concentriq to run anatomic pathology testing for drug improvement throughout a number of laboratories on three continents,” stated Dr. John Cochran, Vice President and Chief Medical Officer at IQVIA Laboratories. “Proscia has a daring imaginative and prescient for what pathology software program could be. Fifth Technology applies that very same pondering to AI, elevating pathologists and scientists and rising pathology’s position in precision medication.”
When Will the Fifth Technology of Concentriq Be Accessible?
It’s out there now to present prospects by means of Proscia’s early entry program. Preliminary deployments start this month with choose laboratories and biopharmaceutical firms, and broader availability follows later this yr.
Organizations not but on Concentriq can request precedence entry by contacting Proscia.
How Can I Be taught Extra In regards to the Fifth Technology of Concentriq?
Register here to affix Proscia’s reside product walkthrough and demonstration webinar on July 28, 2026 at 12PM ET.
About Proscia
Proscia is the pathology AI firm rewiring pathology for precision medication throughout drug discovery, improvement, and analysis. Its Concentriq platform brings intelligence to the scientists, pathologists, and laboratory leaders behind probably the most vital choices in medication, serving to extra breakthroughs attain the sufferers they have been made for. Proscia is trusted by 16 of the highest 20 pharmaceutical firms and was named World 2026 Greatest in KLAS for Digital Pathology in Europe. Be taught extra at proscia.com, and observe Proscia on LinkedIn and X.
Contact
Sydney Fenkell
VP, Advertising and marketing Communications
sydney@proscia.com
215.816.3436
_______________
1 The Concentriq portfolio contains distinct configurations. Concentriq AP-Dx is FDA-cleared for main analysis in the USA (U.S.) with the Hamamatsu NanoZoomer® S360MD Slide scanner and is licensed in Canada and CE‑marked beneath the EU IVDR for main analysis. Concentriq AP-Dx isn’t meant to be used with frozen sections, cytology, or non-FFPE hematopathology specimens. Concentriq AP and Concentriq LS are for Analysis Use Solely. Not to be used in diagnostic procedures. Proscia’s AI functions can be found for analysis use solely. Most of the options described herein are a part of Concentriq AP and will not be to be used in scientific analysis.
2 Royal Faculty of Pathologists. Workforce census 2025: morale and wellbeing of the pathology workforce. Royal Faculty of Pathologists; August 11, 2025. Accessed March 23, 2026. https://www.rcpath.org/discover-pathology/news/workforce-census-2025-morale-and-wellbeing-of-the-pathology-workforce.html
3 Computerized tiering with chilly storage cuts long-term prices by greater than half for labs already utilizing tiered storage. Based mostly on modeling with actual lab utilization information, together with retrieval charges. Precise financial savings could range by coverage or deployment.
